NAFLD活动度评分变化与纤维化变化临床关联
本研究旨在探讨非酒精性脂肪性肝病(NAFLD)患者中NAFLD活动度评分(NAS)变化与纤维化分期变化之间的关联。研究纳入具有配对肝活检评估的NAFLD患者,分析NAS变化与纤维化变化的关系。
要点
- NAS评分≥2分改善常用作NASH临床试验终点。
- 肝纤维化是NAFLD预后最强组织学预测因子。
- 需验证NAS变化与纤维化变化之间的关联。
核心结论
- NAS变化与纤维化分期变化之间的关联尚未完全验证。
研究设计与样本
- 研究纳入具有配对肝活检评估的NAFLD患者,分析NAS变化与纤维化分期的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Nonalcoholic fatty liver disease (NAFLD) Activity Score (NAS) has been applied as a method for evaluating treatment response, and a ≥2-point improvement in NAS has been commonly used as an accepted end point in phase 2b clinical trials in nonalcoholic steatohepatitis.1,2 Although liver fibrosis is the strongest histologic predictor of liver-related outcome and all-cause mortality in NAFLD,3,4 the association between change in NAS and change in fibrosis stage has not been fully verified. Therefore, we aimed to examine the association between change in NAS and change in fibrosis stage in well-characterized patients with NAFLD who had a paired liver biopsy assessment.
引用
- Tamaki N, Munaganuru N, Jung J, et al. Clinical Utility of Change in Nonalcoholic Fatty Liver Disease Activity Score and Change in Fibrosis in NAFLD. Clin Gastroenterol Hepatol. 2020. PMID: 33157318. doi:10.1016/j.cgh.2020.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。